Chronic Plaque Psoriasis Therapeutics Market - Global Outlook and Forecast 2022-2028

March 2022 | 61 pages | ID: C398FC2F2AC4EN
Market Monitor Global

Abstracts

Psoriasis is an autoimmune disease which is characterized by scaly patches of skin with inflammation and causes excessive production of new skin cells. Presently, there are no long term therapeutics available for the treatment of psoriasis. Chronic Plaque psoriasis is the one of the most common type of psoriasis. This disease condition is associated with several risk factors such as infection, psychological stress and others. Diagnosis of chronic plaque psoriasis is based on clinical appearance, is the case is severe then biopsy is recommended by the healthcare professionals in order to distinguish it from other conditions such as seborrheic dermatitis, ichen simplex chronicus and others.

This report contains market size and forecasts of Chronic Plaque Psoriasis Therapeutics in Global, including the following market information:

Global Chronic Plaque Psoriasis Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Chronic Plaque Psoriasis Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Clinical Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Chronic Plaque Psoriasis Therapeutics include Abbvie, Novartis International, Pfizer, Merck, Astelllas Pharma and GlaxoSmithKline, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Chronic Plaque Psoriasis Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Chronic Plaque Psoriasis Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Chronic Plaque Psoriasis Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Clinical
• Non-Clinical
• Inactive

Global Chronic Plaque Psoriasis Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Chronic Plaque Psoriasis Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Ambulatory Surgical Centers
• Others

Global Chronic Plaque Psoriasis Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Chronic Plaque Psoriasis Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Chronic Plaque Psoriasis Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Chronic Plaque Psoriasis Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Abbvie
• Novartis International
• Pfizer
• Merck
• Astelllas Pharma
• GlaxoSmithKline

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Chronic Plaque Psoriasis Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Chronic Plaque Psoriasis Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CHRONIC PLAQUE PSORIASIS THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Chronic Plaque Psoriasis Therapeutics Market Size: 2021 VS 2028
2.2 Global Chronic Plaque Psoriasis Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Chronic Plaque Psoriasis Therapeutics Players in Global Market
3.2 Top Global Chronic Plaque Psoriasis Therapeutics Companies Ranked by Revenue
3.3 Global Chronic Plaque Psoriasis Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Chronic Plaque Psoriasis Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Chronic Plaque Psoriasis Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Chronic Plaque Psoriasis Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Chronic Plaque Psoriasis Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Chronic Plaque Psoriasis Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Chronic Plaque Psoriasis Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Clinical
  4.1.3 Non-Clinical
  4.1.4 Inactive
4.2 By Type - Global Chronic Plaque Psoriasis Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Chronic Plaque Psoriasis Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Chronic Plaque Psoriasis Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Chronic Plaque Psoriasis Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Chronic Plaque Psoriasis Therapeutics Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Ambulatory Surgical Centers
  5.1.4 Others
5.2 By Application - Global Chronic Plaque Psoriasis Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Chronic Plaque Psoriasis Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Chronic Plaque Psoriasis Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Chronic Plaque Psoriasis Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Chronic Plaque Psoriasis Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Chronic Plaque Psoriasis Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Chronic Plaque Psoriasis Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Chronic Plaque Psoriasis Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Chronic Plaque Psoriasis Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Chronic Plaque Psoriasis Therapeutics Revenue, 2017-2028
  6.3.2 US Chronic Plaque Psoriasis Therapeutics Market Size, 2017-2028
  6.3.3 Canada Chronic Plaque Psoriasis Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Chronic Plaque Psoriasis Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Chronic Plaque Psoriasis Therapeutics Revenue, 2017-2028
  6.4.2 Germany Chronic Plaque Psoriasis Therapeutics Market Size, 2017-2028
  6.4.3 France Chronic Plaque Psoriasis Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Chronic Plaque Psoriasis Therapeutics Market Size, 2017-2028
  6.4.5 Italy Chronic Plaque Psoriasis Therapeutics Market Size, 2017-2028
  6.4.6 Russia Chronic Plaque Psoriasis Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Chronic Plaque Psoriasis Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Chronic Plaque Psoriasis Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Chronic Plaque Psoriasis Therapeutics Revenue, 2017-2028
  6.5.2 China Chronic Plaque Psoriasis Therapeutics Market Size, 2017-2028
  6.5.3 Japan Chronic Plaque Psoriasis Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Chronic Plaque Psoriasis Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Chronic Plaque Psoriasis Therapeutics Market Size, 2017-2028
  6.5.6 India Chronic Plaque Psoriasis Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Chronic Plaque Psoriasis Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Chronic Plaque Psoriasis Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Chronic Plaque Psoriasis Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Chronic Plaque Psoriasis Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Chronic Plaque Psoriasis Therapeutics Market Size, 2017-2028
  6.7.3 Israel Chronic Plaque Psoriasis Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Chronic Plaque Psoriasis Therapeutics Market Size, 2017-2028
  6.7.5 UAE Chronic Plaque Psoriasis Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Abbvie
  7.1.1 Abbvie Corporate Summary
  7.1.2 Abbvie Business Overview
  7.1.3 Abbvie Chronic Plaque Psoriasis Therapeutics Major Product Offerings
  7.1.4 Abbvie Chronic Plaque Psoriasis Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 Abbvie Key News
7.2 Novartis International
  7.2.1 Novartis International Corporate Summary
  7.2.2 Novartis International Business Overview
  7.2.3 Novartis International Chronic Plaque Psoriasis Therapeutics Major Product Offerings
  7.2.4 Novartis International Chronic Plaque Psoriasis Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 Novartis International Key News
7.3 Pfizer
  7.3.1 Pfizer Corporate Summary
  7.3.2 Pfizer Business Overview
  7.3.3 Pfizer Chronic Plaque Psoriasis Therapeutics Major Product Offerings
  7.3.4 Pfizer Chronic Plaque Psoriasis Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 Pfizer Key News
7.4 Merck
  7.4.1 Merck Corporate Summary
  7.4.2 Merck Business Overview
  7.4.3 Merck Chronic Plaque Psoriasis Therapeutics Major Product Offerings
  7.4.4 Merck Chronic Plaque Psoriasis Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 Merck Key News
7.5 Astelllas Pharma
  7.5.1 Astelllas Pharma Corporate Summary
  7.5.2 Astelllas Pharma Business Overview
  7.5.3 Astelllas Pharma Chronic Plaque Psoriasis Therapeutics Major Product Offerings
  7.5.4 Astelllas Pharma Chronic Plaque Psoriasis Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 Astelllas Pharma Key News
7.6 GlaxoSmithKline
  7.6.1 GlaxoSmithKline Corporate Summary
  7.6.2 GlaxoSmithKline Business Overview
  7.6.3 GlaxoSmithKline Chronic Plaque Psoriasis Therapeutics Major Product Offerings
  7.6.4 GlaxoSmithKline Chronic Plaque Psoriasis Therapeutics Revenue in Global Market (2017-2022)
  7.6.5 GlaxoSmithKline Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Chronic Plaque Psoriasis Therapeutics Market Opportunities & Trends in Global Market
Table 2. Chronic Plaque Psoriasis Therapeutics Market Drivers in Global Market
Table 3. Chronic Plaque Psoriasis Therapeutics Market Restraints in Global Market
Table 4. Key Players of Chronic Plaque Psoriasis Therapeutics in Global Market
Table 5. Top Chronic Plaque Psoriasis Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Chronic Plaque Psoriasis Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Chronic Plaque Psoriasis Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Chronic Plaque Psoriasis Therapeutics Product Type
Table 9. List of Global Tier 1 Chronic Plaque Psoriasis Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Chronic Plaque Psoriasis Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Chronic Plaque Psoriasis Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Chronic Plaque Psoriasis Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Chronic Plaque Psoriasis Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Chronic Plaque Psoriasis Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Chronic Plaque Psoriasis Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Chronic Plaque Psoriasis Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Chronic Plaque Psoriasis Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Chronic Plaque Psoriasis Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Chronic Plaque Psoriasis Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Chronic Plaque Psoriasis Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Chronic Plaque Psoriasis Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Chronic Plaque Psoriasis Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Chronic Plaque Psoriasis Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Chronic Plaque Psoriasis Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Chronic Plaque Psoriasis Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Chronic Plaque Psoriasis Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Chronic Plaque Psoriasis Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Chronic Plaque Psoriasis Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Chronic Plaque Psoriasis Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Abbvie Corporate Summary
Table 31. Abbvie Chronic Plaque Psoriasis Therapeutics Product Offerings
Table 32. Abbvie Chronic Plaque Psoriasis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Novartis International Corporate Summary
Table 34. Novartis International Chronic Plaque Psoriasis Therapeutics Product Offerings
Table 35. Novartis International Chronic Plaque Psoriasis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Pfizer Corporate Summary
Table 37. Pfizer Chronic Plaque Psoriasis Therapeutics Product Offerings
Table 38. Pfizer Chronic Plaque Psoriasis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Merck Corporate Summary
Table 40. Merck Chronic Plaque Psoriasis Therapeutics Product Offerings
Table 41. Merck Chronic Plaque Psoriasis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Astelllas Pharma Corporate Summary
Table 43. Astelllas Pharma Chronic Plaque Psoriasis Therapeutics Product Offerings
Table 44. Astelllas Pharma Chronic Plaque Psoriasis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. GlaxoSmithKline Corporate Summary
Table 46. GlaxoSmithKline Chronic Plaque Psoriasis Therapeutics Product Offerings
Table 47. GlaxoSmithKline Chronic Plaque Psoriasis Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Chronic Plaque Psoriasis Therapeutics Segment by Type in 2021
Figure 2. Chronic Plaque Psoriasis Therapeutics Segment by Application in 2021
Figure 3. Global Chronic Plaque Psoriasis Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Chronic Plaque Psoriasis Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Chronic Plaque Psoriasis Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Chronic Plaque Psoriasis Therapeutics Revenue in 2021
Figure 8. By Type - Global Chronic Plaque Psoriasis Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Chronic Plaque Psoriasis Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Chronic Plaque Psoriasis Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Chronic Plaque Psoriasis Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Chronic Plaque Psoriasis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Chronic Plaque Psoriasis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Chronic Plaque Psoriasis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Chronic Plaque Psoriasis Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Chronic Plaque Psoriasis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Chronic Plaque Psoriasis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Chronic Plaque Psoriasis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Chronic Plaque Psoriasis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Chronic Plaque Psoriasis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Chronic Plaque Psoriasis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Chronic Plaque Psoriasis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Chronic Plaque Psoriasis Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Chronic Plaque Psoriasis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Chronic Plaque Psoriasis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Chronic Plaque Psoriasis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Chronic Plaque Psoriasis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Chronic Plaque Psoriasis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Chronic Plaque Psoriasis Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Chronic Plaque Psoriasis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Chronic Plaque Psoriasis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Chronic Plaque Psoriasis Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Chronic Plaque Psoriasis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Chronic Plaque Psoriasis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Chronic Plaque Psoriasis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Chronic Plaque Psoriasis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Abbvie Chronic Plaque Psoriasis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Novartis International Chronic Plaque Psoriasis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Pfizer Chronic Plaque Psoriasis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Merck Chronic Plaque Psoriasis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Astelllas Pharma Chronic Plaque Psoriasis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. GlaxoSmithKline Chronic Plaque Psoriasis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)